MedTrace Logo

Normalizing HPV Vaccination in Preteens With a Serious Video Game

NCT04627298 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2020-11-13

No results posted yet for this study

Summary

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States and causes genital warts and cancers in both females and males. Vaccination against HPV is recommended for routine use in those aged 11-12 years old, yet is underutilized. The study's premise is that preteens are relevant decision makers who can be motivated to initiate and complete the HPV vaccine series (assuming parental consent and provider recommendation). This study evaluates a serious video game to engage preteens in the decision to pursue HPV vaccination. The hypothesis is that preteens who are assigned to the video game will be more likely to initiate and complete HPV vaccination than preteens who are not assigned to the video game.

Conditions

  • Human Papillomavirus

Interventions

BEHAVIORAL

educational video game for preteens to support HPV vaccination

An educational video game developed for 11-12 year olds to increase interest in and decision to pursue HPV vaccination.

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Bernard F. Fuemmeler, PhD · Virginia Commonwealth University

  • Jamie L. Crandell, PhD · University of North Carolina, Chapel Hill

  • Joan Cates, PhD · University of North Carolina, Chapel Hill

  • Sandra J Diehl, MPH · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-09
Primary Completion
2019-04-16
Completion
2019-04-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04627298 on ClinicalTrials.gov